IBANDRONATPOLYMORPH B

European patent · EP1848727 · Deleted

Register entry

Publication number
EP1848727
Application number
EP06701843
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 24, 2006
Published
Oct 31, 2007
Granted
Jun 17, 2015
Deleted
Mar 16, 2022
Reason
Revoked in opposition
IPC classes
C07F 9/38 (2006.01)
A61P 35/00 (2006.01)
Priority
EP 05100687 01.02.2005
PCT application
PCT/EP2006/000579 24.01.2006
PCT publication
WO2006/081962 10.08.2006
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 16, 2022

    Change

    Published in Swissreg on 16.03.2022

  2. Aug 19, 2020

    Deleted, fee unpaid

    Published in Swissreg on 19.08.2020

  3. May 16, 2018

    Transferred

    Owner
    F.Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel → Atnahs Pharma UK Limited, Suite 1, 3rd Floor, 11-22 St James' Square, London SW1Y 4LB, United Kingdom

    Published in Swissreg on 16.05.2018

  4. May 16, 2018

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 16.05.2018

  5. Jun 17, 2015

    Granted

    Published in Swissreg on 17.06.2015

Parties

Inventor

EIERMANN, Uwe

68526 Ladenburg, DE

JUNGHANS, Bernd

68535 Edingen-Neckarhausen, DE

KNIPP, Bernhard

51515 Kuerten-Olpe, DE

SATTELKAU, Tim

67065 Ludwigshafen, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.